BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

BIM

115.2

+1.5%↑

SRT3

228.5

-0.65%↓

GXI

55.15

+2.89%↑

ICAD

20.98

-1.04%↓

Search

Carl Zeiss Meditec AG

Open

SectorGezondheidszorg

58.7 0.69

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

57.75

Max

59.1

Belangrijke statistieken

By Trading Economics

Inkomsten

-45M

16M

Verkoop

-89M

491M

K/W

Sectorgemiddelde

31.977

57.333

EPS

0.36

Dividendrendement

1.06

Winstmarge

3.201

Werknemers

2,066

EBITDA

-41M

37M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+3.4% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.06%

2.63%

Volgende Winsten

13 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-153M

5B

Vorige openingsprijs

58.01

Vorige sluitingsprijs

58.7

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Carl Zeiss Meditec AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2025, 08:20 UTC

Marktinformatie

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

28 okt 2024, 11:15 UTC

Marktinformatie
Winsten

Med-Tech Stocks Drop Amid Subdued Demand in China -- Market Talk

Peer Vergelijking

Prijswijziging

Carl Zeiss Meditec AG Prognose

Koersdoel

By TipRanks

3.4% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 60.75 EUR  3.4%

Hoogste 86.5 EUR

Laagste 41 EUR

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Carl Zeiss Meditec AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

10 ratings

3

Buy

6

Hold

1

Sell

Technische score

By Trading Central

57.6 / 58.8Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.